Provided by Tiger Trade Technology Pte. Ltd.

Amneal Pharmaceuticals, Inc.

14.82
+0.19001.30%
Post-market: 14.820.00000.00%17:44 EST
Volume:1.92M
Turnover:28.52M
Market Cap:4.66B
PE:921.01
High:14.99
Open:14.65
Low:14.57
Close:14.63
52wk High:15.00
52wk Low:6.69
Shares:314.36M
Float Shares:168.50M
Volume Ratio:1.05
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0161
EPS(LYR):-0.3783
ROE:-881.26%
ROA:6.79%
PB:-42.56
PE(LYR):-39.18

Loading ...

Feb 03, 2026

Major Issues Report

Form 8-K - Current report
Jan 29, 2026

Major Issues Report

Form 8-K - Current report
Jan 13, 2026

Major Issues Report

Form 8-K - Current report
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2025

Major Issues Report

Form 8-K - Current report
Aug 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]